The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Revenue by Segment

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Manufacturing and Selling of Medicine	11.88B	11.37B	9.13B	8.48B	7.38B
Manufacturing and Selling of Medicine Growth	4.51%	24.61%	7.61%	14.96%	19.13%
Total	11.88B	11.37B	9.13B	8.48B	7.38B
Total Growth	4.51%	24.61%	7.61%	14.96%	19.13%

Revenue by Geography

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Bangladesh	10.54B	9.90B	7.88B	8.39B	7.28B
Bangladesh Growth	6.48%	25.55%	-6.01%	15.12%	19.02%
Export	188.24M	267.06M	133.26M	93.30M	91.10M
Export Growth	-29.51%	100.41%	42.83%	2.41%	28.28%
Total	10.73B	10.16B	8.02B	8.48B	7.38B
Total Growth	5.53%	26.79%	-5.47%	14.96%	19.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error